<DOC>
	<DOCNO>NCT00219700</DOCNO>
	<brief_summary>To determine safety efficacy 3 x 800 mg/day IBU-PC assess endoscopy incidence adverse event</brief_summary>
	<brief_title>Ibuprofen-PC Compared With Ibuprofen GI Safety Trial</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>moderate osteoarthritis hip and/or knee require chronic pain medication others per protocol sensitivity NSAIDs lecithin hypertension history GI specific problem use medication criterion per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>NSAID-PC</keyword>
	<keyword>IBU-PC</keyword>
</DOC>